Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

Posted by Tyrone Williams on Oct 1st, 2024

StockNews.com initiated coverage on shares of Concord Medical Services (NYSE:CCM – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock.

Concord Medical Services Trading Down 7.4 %

Shares of CCM opened at $6.49 on Friday. Concord Medical Services has a fifty-two week low of $3.82 and a fifty-two week high of $26.70. The firm has a 50-day simple moving average of $6.67 and a 200-day simple moving average of $6.80. The company has a current ratio of 0.32, a quick ratio of 0.30 and a debt-to-equity ratio of 1.14.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.